Answers are grounded in this paper and cite their sources.
Investigates reactivated cryptococcosis risk in persistently infected mice following FTY720 treatment, suggesting preventive strategies are needed.
Tem cells and impairing Th1-mediated immunity. Given the rising use of FTY720, our study highlights its potential risk in patients with subclinical cryptococcosis and underscores the need for preventive strategies to avert disease progression.
No takes yet. Share an insight, caveat, or question.
Yoshida et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: